Effect of patient‐centered self‐management intervention on glycemic control, self‐efficacy, and self‐care behaviors in South Asian adults with type 2 diabetes mellitus: A multicenter randomized controlled trial
Kainat Asmat,Erika Sivarajan Froelicher,Khairunnisa Aziz Dhamani,Raisa Gul,Nazeer Khan
DOI: https://doi.org/10.1111/1753-0407.13611
IF: 4.53
2024-09-14
Journal of Diabetes
Abstract:Highlights T2DM dominates worldwide, especially in the low middle income countries (LMICs) of South Asia. Despite acknowledging self‐management as the corner stone in T2DM, LMICs face an implementation gap due to lacking policies and the fragmented care systems, neglecting crucial personal, behavioral, and social factors. In this first large‐scale multicenter randomized controlled trial conducted in Pakistan, a LMIC, the nurse‐led PACE‐SMI demonstrated significant improvement in HbA1c, self‐efficacy, and self‐care behaviors in adults with T2DM at 3 months. Considering the substantial health and economic impact of T2DM in LMICs, evidence presented in this study holds implications for the healthcare policies, advocating for integration of PACE‐SMI into standard practice. Background This study aimed to test the efficacy of patient‐centered self‐management intervention (PACE‐SMI) to improve HbA1c, self‐efficacy, and self‐care behaviors in adults with type 2 diabetes mellitus (T2DM). Methods In this multicenter, parallel two‐arm randomized controlled trial, 612 adults with T2DM and HbA1c ≥ 7% were enrolled and assigned to the control group (n = 310) and the intervention group (n = 302) using stratified permuted block randomization. The control group received usual care, whereas the intervention group received usual care plus nurse‐led, theory‐driven, culturally tailored PACE‐SMI, comprising eight weekly sessions of individualized education, counseling, behavioral training, and home visit. Outcomes were assessed at baseline, postintervention, and 3 months follow‐up. Results Data at 3 months were provided by 583 participants (control: n = 295, intervention: n = 288). Per‐protocol analysis showed that the intervention group had a lower mean HbA1c (8.49% [standard deviation (SD), 1.58]) than the control group (8.74% [SD, 1.62]), with small yet statistically significant mean difference of 0.25% (95% confidence interval [CI], −0.01 to 0.51; Cohen's d = 0.16; p = 0.03). Self‐efficacy and self‐care behaviors significantly improved in the intervention group (116.89 [SD, 25.50] and 70.01 [SD, 17.97]) compared to the control group (75.43 [SD, 18.99] and 51.54 [SD, 12.04]), with mean differences of 41.48 (95% CI, 37.83–45.13; Cohen's d = 1.84; p
endocrinology & metabolism